Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by I.E. Fadimu
Total Records ( 1 ) for I.E. Fadimu
  P.H. Mamman , W.P. Mshelia and I.E. Fadimu
  This study was carried out to isolate possible aerobic bacteria and fungi that may be associated with cases of ulcerative lymphangitis in horses in Kano metropolis and also carry out an antimicrobial susceptibility tests on the bacteria isolated. In this study, 36 wound swabs were collected from horses with clinical cases of ulcerative lymphangitis in Kano metropolis, Nigeria for purposes of culture, isolation and identification of bacterial and fungal organisms associated with the disease. Corynebacterium pseudotuberculosis, Staphylococcus sp. and Streptococcus sp. were isolated with frequencies of 22.22, 30.56 and 11.11%, respectively; 36.11% of the samples yielded no bacterial isolates. 38.46% of the fungal organisms isolated were Aspergillus fumigatus, 26.92% were Aspergillus niger, 23.08% were Mucor sp. and 11.54% were Trichophyton sp. The antibiotic sensitivity carried out on the bacterial isolates showed fluroquinolones (ciprofloxacin and perfloxacin) and amoxicillin to be the most effective against most of the organisms isolated but at varying degrees. In this study, both bacteria and fungi were implicated in the disease process of ulcerative lymphangitis in Kano, Nigeria and the breeds most affected were: the ‘Arewa’, ‘Sudan’ and ‘Talon’ breeds (all Arabian cross in nature). In the treatment of ulcerative lymphangitis, an antimicrobial sensitivity should be carried out in order to ascertain the most sensitive drug(s) to be used and where this is not possible, the fluoroquinolones or the penicillins could be used alongside anti-mycotic agents.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility